CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Equimatrix +3 moredrug
Likely dose
Equimatrix 2gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01911819
NCT01911819N/ACompleted
CompareCT.gov

A Histomorphometric Analysis of Bone Formation With Three Different Bone Graft Materials Following Sinus Augmentation

Loma Linda University·interventional·Posted Jul 30, 2013·Updated Dec 13, 2017

In Brief

A clinical study evaluating Sinus augmentation, Equimatrix, and 2 other interventions for Inadequate Bone Height in Maxillary Posterior Area. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The purpose of this study is to compare new bone formation following bone graft in sinus using three different commercially available bone graft materials. The study hypothesis is that there is no difference in new bone formation among three bone graft materials under microscope.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInadequate Bone Height in Maxillary Posterior Area
CountriesUnited States
CollaboratorsAmerican Regent, Inc.

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 30, 2013
Enrollment StartDec 1, 2013
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 12.9 years ago

Interventions

Sinus augmentationprocedure

Equimatrixdrug

Equimatrix cancellous particle size 0.2-1mm approximately 2g (4cc)

OSSIF-i semdrug

OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 2cc x 2

Bio-ossdrug

Bio-oss small granules cancellous 0.25-1mm, approximately 2g (4cc)